| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $509,413,561 ) (Continued on the next page) |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01DC024001 | Cortical mechanisms underlying hearing deficits in noisy backgrounds after noise trauma | 000 | 1 | NIH | 7/14/2026 | $464,646 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21CA313364 | Targeting Tr1 to enhance the efficacy of cancer vaccines | 000 | 1 | NIH | 5/14/2026 | $399,829 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K08GM164635 | Investigating the Role of Proton-Sensing G Protein Coupled Receptors in Trauma and Hemorrhagic Shock | 000 | 1 | NIH | 5/14/2026 | $200,613 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21AI198155 | Identification of Host Factors that Mediate the Nuclear Retention of Unspliced and Partially Spliced HIV-1 Transcripts | 000 | 1 | NIH | 4/1/2026 | $427,626 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F31AI197561 | Heightened cholesterol efflux by lymph node macrophages facilitates their transfer of large lymph-borne antigen to resident dendritic cells | 001 | 1 | NIH | 4/24/2026 | $576 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01AG091773 | Sleep reinforces homeostatic set-points in neural activity and mitigates neurodegenerative disease | 000 | 1 | NIH | 2/6/2026 | $578,856 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01GM163049 | Defining the PS neighborhood proteins on apoptotic cells and their impact on efferocytosis | 000 | 1 | NIH | 2/23/2026 | $388,750 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01DK146938 | Structural and Functional Mechanisms of Podocin in Glomerular Membrane Organization and Kidney Disease | 000 | 1 | NIH | 4/27/2026 | $388,750 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21EY038491 | Novel Statistical Models for Visual Field Progression in the Ocular Hypertension Treatment Study | 000 | 1 | NIH | 4/3/2026 | $427,625 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30EY038618 | Elucidating the role of SAMD7 in photoreceptor transcriptional regulation. | 001 | 1 | NIH | 4/21/2026 | $0 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30EY038618 | Elucidating the role of SAMD7 in photoreceptor transcriptional regulation. | 000 | 1 | NIH | 4/21/2026 | $37,249 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21DE034951 | Radiation-guided theranostic agents to monitor response to oral cancer treatment | 000 | 1 | NIH | 2/6/2026 | $427,625 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F31DA066305 | OPioid use disorder Team structure In emergency Medicine: Associations with short- and Long-term outcomes (OPTIMAL) | 001 | 1 | NIH | 4/21/2026 | $0 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F31DA066305 | OPioid use disorder Team structure In emergency Medicine: Associations with short- and Long-term outcomes (OPTIMAL) | 000 | 1 | NIH | 4/21/2026 | $37,312 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | U01DA064170 | Long term impact of maternal opioid use and management strategies on neurodevelopment in rodent offspring | 000 | 1 | NIH | 4/13/2026 | $733,457 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30AI197428 | Viral and host determinants of orthobunyavirus entry. | 000 | 1 | NIH | 5/19/2026 | $37,249 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | RF1MH090786 | Developmental Pathways to Borderline Personality Disorder: Longitudinal Observational, Clinical, and Neural Predictors From Early Childhood to Young Adulthood | 000 | 14 | NIH | 7/15/2026 | $1,405,361 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K23NS146687 | Transcriptomic Signatures of Ischemic Stroke: Unlocking Human-Specific Targets for Cerebroprotection | 000 | 1 | NIH | 4/7/2026 | $231,264 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K08DK146198 | Barrestin-mediated desensitization of PTH1R at the intersection of PTH and PTHrP biologic actions | 000 | 1 | NIH | 2/9/2026 | $192,288 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30AI197428 | Viral and host determinants of orthobunyavirus entry. | 001 | 1 | NIH | 5/19/2026 | $0 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21HD118485 | Retinoic acid signaling and uterine epithelial cell fate | 000 | 1 | NIH | 5/19/2026 | $427,625 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA308205 | Mechanisms appropriated for growth and survival of tumors driven by constitutively active GNAQ/11 | 000 | 1 | NIH | 8/4/2026 | $646,785 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01EY037720 | Neural mechanisms of lightness constancy | 000 | 1 | NIH | 8/3/2026 | $571,643 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA309209 | Optimizing HER2 modulation in HER2-low breast tumors to enhance ADC therapy | 000 | 1 | NIH | 7/10/2026 | $645,323 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | P01AI197186 | Antibiotic-sparing strategies for treatment of bacterial infections | 000 | 1 | NIH | 6/25/2026 | $1,500,000 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K25AG095391 | Predicting symptom onset and clinical progression with blood biomarkers of Alzheimer disease | 000 | 1 | NIH | 8/3/2026 | $151,480 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA316361 | PET Imaging CD163+ Tumor Associated Macrophages in Head and Neck Cancer | 000 | 1 | NIH | 7/10/2026 | $623,616 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R35GM162028 | Uncovering the molecular principles of intracellular electrochemistry | 000 | 1 | NIH | 3/24/2026 | $410,520 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K99HD122257 | Study the impact of Bacterial Vaginosis toxins on mouse and human sperm function | 000 | 1 | NIH | 5/19/2026 | $125,142 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01HL181056 | Pannexin Channel Activation in Live and Apoptotic Cells during Lung Inflammation and Repair | 000 | 1 | NIH | 7/16/2026 | $1,399,133 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R35GM161656 | Mechanosensitive mechanisms regulating cellular coordination during tissue morphogenesis and patterning | 000 | 1 | NIH | 5/18/2026 | $483,175 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA305974 | Expand and pull: long-acting IL-7 and oncolytic virus to treat glioblastoma | 000 | 1 | NIH | 5/19/2026 | $645,185 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01AI198352 | Targeting VLDLR to prevent both GvHD and leukemia relapse | 000 | 1 | NIH | 5/19/2026 | $388,750 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21NS149726 | Reprogramming astrocytes to promote neural repair | 000 | 1 | NIH | 7/6/2026 | $245,874 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA302883 | Development of novel neoantigen-based spherical nucleic acid immunotherapeutics | 000 | 1 | NIH | 7/7/2026 | $562,550 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R35GM163857 | Fat cadherin function in planar polarity | 000 | 1 | NIH | 7/6/2026 | $466,500 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F31AI194547 | Making and Breaking the Cell Wall of the Pathogenic Fungus Cryptococcus neoformans | 001 | 1 | NIH | 6/23/2026 | $0 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA298938 | Radiation-guided antibody-drug conjugates for cancer therapy | 000 | 1 | NIH | 3/30/2026 | $542,644 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F31AI194547 | Making and Breaking the Cell Wall of the Pathogenic Fungus Cryptococcus neoformans | 000 | 1 | NIH | 6/23/2026 | $37,312 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21CA307944 | Rational Design of Next-Generation Engineered T Cells for Enhanced Cancer Immunotherapy | 000 | 1 | NIH | 3/30/2026 | $399,829 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | T35HL182831 | Surgery, Technology and Engineering Mentorship for Medical Students (STEMS) Program | 000 | 1 | NIH | 7/7/2026 | $78,305 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01AI184936 | Defining the critical functions of the stem-loop II motif in the lifecycle of astrovirus VA1 | 000 | 1 | NIH | 7/6/2026 | $388,750 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01GM163062 | Real-Time Software-Hardware Integration for Dynamic Control of Tissue Mechanical Environments | 000 | 1 | NIH | 3/31/2026 | $1,244,000 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | U01AI195139 | Phase 1b/2a Evaluation of the Safety and Tolerability of SYN-004 in Adult Allogeneic Hematopoietic Cell Transplantation (allo-HCT) Recipients | 000 | 1 | NIH | 3/30/2026 | $919,820 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01AR087006 | Leveraging Human Skin Dendritic Cells to Unravel Immune Mechanisms and Advance Therapies for Skin Inflammation | 000 | 1 | NIH | 7/7/2026 | $483,286 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K08HL185919 | Immuno-Metabolic Drivers of Chronic Rejection after Lung Transplant | 000 | 1 | NIH | 6/23/2026 | $169,140 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30CA313986 | Determining the functional epigenomic consequences of HPV viral oncogene expression heterogeneity in oropharyngeal squamous cell carcinoma | 001 | 1 | NIH | 4/16/2026 | $576 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30CA313986 | Determining the functional epigenomic consequences of HPV viral oncogene expression heterogeneity in oropharyngeal squamous cell carcinoma | 000 | 1 | NIH | 3/30/2026 | $36,673 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01AI183261 | Microbial and Host Factors in the Progression to Celiac Disease | 000 | 3 | NIH | 4/28/2026 | $764,474 |
|
